Heterologous recombinant expression of non-originator NISTmAb

The successful development and regulatory approval of originator and biosimilar therapeutic proteins requires a systems approach to upstream and downstream processing as well as product characterization and quality control. Innovation in process design and control, product characterization strategie...

Descripción completa

Detalles Bibliográficos
Autores principales: Kashi, Lila, Yandrofski, Katharina, Preston, Renae J., Arbogast, Luke W., Giddens, John P., Marino, John P., Schiel, John E., Kelman, Zvi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2018
Materias:
Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6152460/
https://www.ncbi.nlm.nih.gov/pubmed/29958062
http://dx.doi.org/10.1080/19420862.2018.1486355

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6152460/
https://www.ncbi.nlm.nih.gov/pubmed/29958062
http://dx.doi.org/10.1080/19420862.2018.1486355

Ejemplares similares